Julie B. Feder serves as Executive at Aura Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Julie B. Feder has executed 8 insider transactions totaling $145.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 1, 2024 involved receiving (via award) 71,285 shares valued at $0.
Julie B. Feder currently holds 134,276 shares of Aura Biosciences, Inc. (AURA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julie B. Feder has been a net seller of AURA stock. They have purchased $0 and sold $145.7K worth of shares.
Julie B. Feder's most recent insider trade was on Feb 1, 2024, when they sold 71,285 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $7.64 |
| Discretionary |
| Nov 6, 2023 | AURA | $10.7K | Option Exercise | 3,900 | $2.74 | Planned |
| Nov 6, 2023 | AURA | $47.1K | Sale | 3,900 | $12.07 | Planned |
| Oct 30, 2023 | AURA | $23.1K | Sale | 3,385 | $6.82 | Discretionary |
| Jan 19, 2023 | AURA | $0 | Award | 48,750 | $N/A | Discretionary |
| Oct 31, 2022 | AURA | $25.1K | Sale | 2,015 | $12.45 | Discretionary |
| Oct 28, 2021 | AURA | $0 | Award | 26,250 | $N/A | Discretionary |